These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2285990)
1. Regioselective N-acetylation as a route of nitro-9-phenylenediamine metabolism by rat liver cytosol. Nakao M; Goto Y; Matsuki Y; Hiratsuka A; Watabe T Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2561-6. PubMed ID: 2285990 [TBL] [Abstract][Full Text] [Related]
2. Reductive metabolism of nitro-p-phenylenediamine by rat liver. Nakao M; Goto Y; Hiratsuka A; Watabe T Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):177-80. PubMed ID: 2049801 [TBL] [Abstract][Full Text] [Related]
3. Distribution, excretion, and metabolism of nitro-p-phenylenediamine in rats. Nakao M; Takeda Y J Toxicol Environ Health; 1983 Jan; 11(1):93-100. PubMed ID: 6827626 [TBL] [Abstract][Full Text] [Related]
4. The carcinogenicity of certain derivatives of p-dimethylaminozobenz in the rat. MILLER JA; MILLER EC J Exp Med; 1948 Feb; 87(2):139-56. PubMed ID: 18911175 [TBL] [Abstract][Full Text] [Related]
5. N-Acetylation of p-aminobenzoic acid and p-phenylenediamine in primary porcine urinary bladder epithelial cells and in the human urothelial cell line 5637. Föllmann W; Blaszkewicz M; Behm C; Degen GH; Golka K J Toxicol Environ Health A; 2012; 75(19-20):1206-15. PubMed ID: 22994574 [TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Turesky RJ; Lang NP; Butler MA; Teitel CH; Kadlubar FF Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of the hair dye component, nitro-p-phenylenediamine, in the rat. Nakao M; Gotoh Y; Matsuki Y; Hiratsuka A; Watabe T Chem Pharm Bull (Tokyo); 1987 Feb; 35(2):785-91. PubMed ID: 3594688 [No Abstract] [Full Text] [Related]
8. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases. Flammang TJ; Kadlubar FF Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755 [TBL] [Abstract][Full Text] [Related]
9. The metabolism and N-oxide reduction of olaquindox in liver preparations of rats, pigs and chicken. Liu ZY; Huang LL; Chen DM; Dai MH; Tao YF; Yuan ZH Toxicol Lett; 2010 May; 195(1):51-9. PubMed ID: 20219653 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous penetration and metabolism of 2-nitro-p-phenylenediamine in human and fuzzy rat skin. Yourick JJ; Bronaugh RL Toxicol Appl Pharmacol; 2000 Jul; 166(1):13-23. PubMed ID: 10873714 [TBL] [Abstract][Full Text] [Related]
11. N-acetylation as a route of 2,4-toluenediamine metabolism by hamster liver cytosol. Glinsukon T; Benjamin T; Grantham PH; Lewis NL; Weisburger EK Biochem Pharmacol; 1976 Jan; 25(1):95-7. PubMed ID: 1252260 [No Abstract] [Full Text] [Related]
12. Enzymic N-acetylation of 2,4-toluenediamine by liver cytosols from various species. Glinsukon T; Benjamin T; Grantham PH; Weisburger EK; Roller PP Xenobiotica; 1975 Aug; 5(8):475-83. PubMed ID: 241157 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of acetyl-coenzyme A dependent activation of N-hydroxyarylamines by phenolic compounds, pentachlorophenol and 1-nitro-2-naphthol. Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R Chem Biol Interact; 1986 Dec; 60(3):275-85. PubMed ID: 3791493 [TBL] [Abstract][Full Text] [Related]
14. Hepatic N-oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the carcinogen, benzidine. Frederick CB; Weis CC; Flammang TJ; Martin CN; Kadlubar FF Carcinogenesis; 1985 Jul; 6(7):959-65. PubMed ID: 4017176 [TBL] [Abstract][Full Text] [Related]
15. Formation of C8-modified deoxyguanosine and C8-modified deoxyadenosine as major DNA adducts from 2-nitropyrene metabolism mediated by rat and mouse liver microsomes and cytosols. Fu PP; Miller DW; Von Tungeln LS; Bryant MS; Lay JO; Huang K; Jones L; Evans FE Carcinogenesis; 1991 Apr; 12(4):609-16. PubMed ID: 2013125 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a novel N-methyl-D-aspartate receptor antagonist (SM-18400): identification of an N-acetylated metabolite and pre-clinical assessment of N-acetylation polymorphism. Yabuki M; Kon-Ya Y; Kataoka M; Shimizudani T; Akao K; Ito M; Kanamaru H; Nakatsuka I Eur J Drug Metab Pharmacokinet; 2003; 28(1):21-9. PubMed ID: 14503661 [TBL] [Abstract][Full Text] [Related]
17. In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline. King RS; Teitel CH; Kadlubar FF Carcinogenesis; 2000 Jul; 21(7):1347-54. PubMed ID: 10874013 [TBL] [Abstract][Full Text] [Related]
18. Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities. Lower GM; Bryan GT Biochem Pharmacol; 1973 Jul; 22(13):1581-8. PubMed ID: 4729805 [No Abstract] [Full Text] [Related]
19. Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificity. Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R Cancer Res; 1986 Sep; 46(9):4362-7. PubMed ID: 3731093 [TBL] [Abstract][Full Text] [Related]
20. Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers. Kim SY; Laxmi YR; Suzuki N; Ogura K; Watabe T; Duffel MW; Shibutani S Drug Metab Dispos; 2005 Nov; 33(11):1673-8. PubMed ID: 16099924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]